Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Pierre Chue & James Chue. (2016) A review of aripiprazole long-acting injection. Current Medical Research and Opinion 32:3, pages 441-452.
Read now
Read now
Brian Godman. (2015) The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine. Journal of Medical Economics 18:11, pages 871-873.
Read now
Read now
Ludovic Samalin, Aurore Nourry, Thomas Charpeaud & Pierre-Michel Llorca. (2014) What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?. Nordic Journal of Psychiatry 68:4, pages 227-235.
Read now
Read now
Birgitta von Schéele, Josephine Mauskopf, Thor-Henrik Brodtkorb, Claire Ainsworth, Carmen Galani Berardo & Anita Patel. (2014) Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research 14:2, pages 235-257.
Read now
Read now
Thomas R. Einarson, Roman Zilbershtein, Jana Skoupá, Šárka Veselá, Madhur Garg & Michiel E. H. Hemels. (2013) Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic. Journal of Medical Economics 16:9, pages 1089-1095.
Read now
Read now
Articles from other publishers (6)
Gisela Paula González, Nebel Silvana Moscoso & Fernando Pablo Lago. (2017) A Review of Clinical and Economic Evaluations Applied to Psychotropic Therapies Used in the Treatment of Schizophrenia in Argentina. PharmacoEconomics - Open 2:3, pages 233-239.
Crossref
Crossref
Trevor C. Chopko & Craig W. Lindsley. (2018) Classics in Chemical Neuroscience: Risperidone. ACS Chemical Neuroscience 9:7, pages 1520-1529.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Corrado Barbui, Marion Bennie, Alexander E Finlayson, Emanuel Raschi & Bjorn Wettermark. (2013) Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications. Journal of Pharmaceutical Health Services Research 4:3, pages 139-150.
Crossref
Crossref
Rahul ManchandaPierre ChueAshok MallaPhil TibboMarc-André RoyRichard WilliamsSrividya IyerDanyael LutgensNicola Banks. (2017) Long-Acting Injectable Antipsychotics: Evidence of Effectiveness and Use. The Canadian Journal of Psychiatry 58:5_suppl, pages 5-13.
Crossref
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Crossref
Gisela Paula Gonzzlez, Nebel Moscoso & Fernando Lago. (2017) A Review of Clinical and Economic Evaluations Applied to Psychotropic Therapies Used in the Treatment of Schizophrenia in Argentina. SSRN Electronic Journal.
Crossref
Crossref